Luoxin Pharmaceutical: Announcement on obtaining a drug registration certificate for the atomized inhalation solution of levosalbutamol hydrochloride
Luoxin Pharmaceutical: Announcement on approval of new indications for injectable LX22001 to conduct clinical trials
Luoxin Pharmaceutical: Announcement on the cancellation of the controlling shareholder\'s share pledge
Luoxin Pharmaceutical: Legal Opinion of the Shanghai Branch of Beijing King & Wood Mallesons on the 2025 Second Extraordinary General Meeting of Shareholders of Luoxin Pharmaceutical Group Co., Ltd.
Luoxin Pharmaceutical: Announcement of Resolutions of the 2025 Second Extraordinary General Meeting of Shareholders
Luoxin Pharmaceutical: Progress Announcement on Providing Guarantees for Holding Subsidiaries
Luoxin Pharmaceutical: Announcement of Resolutions of the 20th Meeting of the Fifth Board of Supervisors
Luoxin Pharmaceutical: Comparison Table of Amendments to the Company\'s Articles of Association
Luoxin Pharmaceutical: Articles of Association (February 2025)
Luo Xin Pharmaceutical: Supervisory Board Rules of Procedure (February 2025)
Luoxin Pharmaceutical: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2025
Luoxin Pharmaceutical: Announcement of Resolutions of the 23rd Meeting of the Fifth Board of Directors
Luo Xin Pharmaceutical: Announcement on the Resignation of Employee Representative Supervisor
Luoxin Pharmaceutical: Legal Opinion of the Shanghai Branch of Beijing King & Wood Mallesons on the 2025 First Extraordinary General Meeting of Shareholders of Luoxin Pharmaceutical Group Co., Ltd.
Luoxin Pharmaceutical: Announcement of Resolutions of the 2025 First Extraordinary General Meeting of Shareholders
Luoxin Pharmaceutical: Progress Announcement on Providing Guarantees for Holding Subsidiaries
Luoxin Pharmaceutical: 2024 Annual Results Forecast
Luoxin Pharmaceutical: Announcement on the controlling shareholder\'s share pledge
Luoxin Pharmaceutical: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025
Luo Xin Pharmaceutical: Announcement of Resolutions of the 19th Meeting of the Fifth Board of Supervisors